Literature DB >> 29955197

Cotrimoxazole-Induced Tremor.

Glen Brown1.   

Abstract

Entities:  

Year:  2018        PMID： 29955197      PMCID： PMC6019079     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  11 in total

1.  Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS.

Authors:  J A Van Gerpen
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Adverse effects of trimethoprim-sulfamethoxazole in a child with dihydropteridine reductase deficiency.

Authors:  R C Woody; M A Brewster
Journal:  Dev Med Child Neurol       Date:  1990-07       Impact factor: 5.449

3.  Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  M J Borucki; D S Matzke; R B Pollard
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

4.  Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS.

Authors:  R S Slavik; M J Rybak; S A Lerner
Journal:  Ann Pharmacother       Date:  1998-02       Impact factor: 3.154

Review 5.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

6.  Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patients.

Authors:  R G Patterson; R L Couchenour
Journal:  Pharmacotherapy       Date:  1999-12       Impact factor: 4.705

7.  Tremors and chorea induced by trimethoprim-sulfamethoxazole in a child with Pneumocystis pneumonia.

Authors:  Jenny Bua; Federico Marchetti; Egidio Barbi; Armando Sarti; Alessandro Ventura
Journal:  Pediatr Infect Dis J       Date:  2005-10       Impact factor: 2.129

8.  Adverse reactions to trimethoprim/sulfamethoxazole in AIDS.

Authors:  Michelle A Floris-Moore; Maria I Amodio-Groton; Michela T Catalano
Journal:  Ann Pharmacother       Date:  2003-12       Impact factor: 3.154

9.  Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection.

Authors:  F Jundt; T Lempert; B Dörken; A Pezzutto
Journal:  Infection       Date:  2004-06       Impact factor: 3.553

10.  Reversible myoclonus, asterixis, and tremor associated with high dose trimethoprim-sulfamethoxazole: a case report.

Authors:  Damon A Gray; Dominic Foo
Journal:  J Spinal Cord Med       Date:  2015-06-25       Impact factor: 1.985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.